Avoro Capital Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-800,000
| Closed | -$7.87M | – | 48 |
|
|
2020
Q1 | $7.87M | Sell |
800,000
-200,000
| -20% | -$1.97M | 0.27% | 36 |
|
|
2019
Q4 | $11.1M | Buy |
+1,000,000
| New | +$11.1M | 0.33% | 26 |
|
|
2019
Q1 | – | Sell |
-4,750,000
| Closed | -$19.5M | – | 34 |
|
|
2018
Q4 | $19.5M | Buy |
4,750,000
+549,969
| +13% | +$2.25M | 1.16% | 17 |
|
|
2018
Q3 | $23.5M | Sell |
4,200,031
-750,000
| -15% | -$4.2M | 1.08% | 20 |
|
|
2018
Q2 | $65.1M | Sell |
4,950,031
-279,588
| -5% | -$3.68M | 2.51% | 15 |
|
|
2018
Q1 | $74.3M | Buy |
5,229,619
+1,935,156
| +59% | +$27.5M | 3.55% | 9 |
|
|
2017
Q4 | $27M | Buy |
+3,294,463
| New | +$27M | 1.75% | 19 |
|